NCT01126034CompletedNot Applicable
Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention
University of Pennsylvania1 site in 1 country85 target enrollmentStarted: March 1, 2007Last updated:
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University of Pennsylvania
- Enrollment
- 85
- Locations
- 1
- Primary Endpoint
- Discontinuation of metoclopramide therapy
Study Overview
Brief Summary
The investigators hypothesized that:
- an intervention targeted at the prescribing physician would increase the rate of a metoclopramide discontinuation among patients prescribed the medication for questionable or unclear indications; and 2) the discontinuation would be durable.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Physicians at University of Pennsylvania Health System who ordered an active metoclopramide prescription with a questionable indication.
Exclusion Criteria
- •Physicians-in-training (e.g., residents, fellows)
- •Physicians how were investigators on this study
- •Physicians serving on the the University of Pennsylvania Drug Use and Effects Committee or Information Technology Oversight Board
Arms & Interventions
intervention
Experimental
Physicians in the intervention group were mailed a written feedback letter regarding their patients who were prescribed questionable metoclopramide therapy. Non-intervention providers received no letter. The letter consisted of the following components:
- The name and medical record # of the patients involved
- Information regarding the metoclopramide prescription: dates, dosage, indication recorded, and the duration of therapy
- A reminder of the adverse effect of long-term metoclopramide therapy
- A recommendation to consider having the patient undergo a trial of metoclopramide discontinuation if appropriate, and documentation of a discussion of risk and benefits of metoclopramide therapy with patients
- A request that the physician document the discontinuation trial in the electronic medical record
Intervention: intervention letter (Other)
non-intervention
No Intervention
No intervention letters were sent to subjects in this arm
Outcomes
Primary Outcomes
Discontinuation of metoclopramide therapy
Time Frame: 12 weeks after intervention period
Twelve weeks after the intervention period, we searched the medical records of patients in the intervention and non-intervention groups to determine whether discontinuation of metoclopramide therapy had taken place.
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
Strategies to Improve Prescribing in Heart Failure PatientsChronic Heart FailureNCT01023438Niguarda Hospital30
Unknown
Not Applicable
Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate MedicationElderlyChronic DiseaseNCT00844025Shin Kong Wu Ho-Su Memorial Hospital120
Recruiting
Not Applicable
Improved Prescribing for Older Nursing Home PatientsOlder PeopleNursing Home ResidentsPrescribingAdvance Care PlanningMedication ReviewsDecision MakingPrescribing PracticesNCT06731361Amsterdam UMC, location VUmc450
Completed
Not Applicable
Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical WardsBacterial InfectionsNCT00431483Ludwig-Maximilians - University of Munich779
Completed
Not Applicable
Educational Intervention to Increase Physician Satisfaction and Effectiveness With a New Electronic Health RecordAttitude of Health PersonnelNCT02015702The Reading Hospital and Medical Center44